Billions of dollars are being pumped into technologies that hope to reduce the effects of ageing. Host Alok Jha explores the latest research in the field—from regenerating organs to rejuvenating cells—and whether these efforts could help to conquer debilitating human diseases. Is anti-ageing more than just a pipe-dream for Silicon Valley startups? 

For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.

Hosted on Acast. See acast.com/privacy for more information.